Semaglutide Brands in India 2026: Full List, Prices and How They Differ

One molecule. More than a dozen Indian makers and a price gap of almost ten times from the cheapest brand to the original.

The name on the box keeps changing. What you really want to know is whether the cheaper one is the same medicine. It is.

Evidence based patient guide by RealMedVision | 11 to 13 minute read

Key takeaways

• Semaglutide is one medicine sold under many brand names in India. After its main patent expired on 20 March 2026, more than a dozen Indian companies launched their own versions (Pearce IP, 2026).
• The big generic brands include Sematrinity and Noveltreat from Sun Pharma, Obeda from Dr Reddy’s, Semaglyn from Zydus, Semasize from Alkem, GLIPIQ from Glenmark, Semanat from Natco and Semabest from MSN. Novo Nordisk still sells the originals: Ozempic, Wegovy and Rybelsus (Pearce IP, 2026).
• Generic injectable semaglutide starts at roughly Rs 1,290 a month. Novo Nordisk’s Ozempic and Wegovy start near Rs 5,660 a month after two price cuts in India (Business Standard, 2026).
• Almost every Indian generic brand is an injection given once a week. The tablet form is still mainly Novo Nordisk’s Rybelsus, because the tablet uses a separate absorption technology with its own patent (Business Standard, 2026).
• The molecule inside every approved brand is the same. Indian generics were cleared by the drug regulator and several completed trials in Indian patients before launch (Pearce IP, 2026).
• Semaglutide is a prescription medicine and it is not safe for everyone. It is not insulin, and it is not the same as Mounjaro, which is a different molecule called tirzepatide.

Semaglutide brands in India now run into the dozens, but they all contain the same active medicine. Semaglutide is the drug inside Novo Nordisk’s Ozempic, Wegovy and Rybelsus. After its main Indian patent expired on 20 March 2026, more than a dozen Indian drugmakers launched their own semaglutide brands, and prices dropped sharply (Pearce IP, 2026).

This guide lists the main semaglutide brands in India, who makes them, what each one is approved to treat, and how the prices compare. If you have been handed an unfamiliar name at the pharmacy and wondered whether it is the real thing, that worry is fair, and the short answer is reassuring.

Quick answer

Semaglutide brands in India include Novo Nordisk’s original Ozempic, Wegovy and Rybelsus, plus generic versions launched after the 20 March 2026 patent expiry. The major generics are Sematrinity, Noveltreat, Obeda, Semaglyn, Semasize, GLIPIQ, Semanat and Semabest. Generic injections start near Rs 1,290 a month, well below the original brands (Pearce IP, 2026).

At a glance

Why one medicine has so many brand names

A brand name belongs to the company, not to the medicine. That is why the same drug can wear many names.

Semaglutide is a prescription GLP-1 receptor agonist used to treat type 2 diabetes and to manage obesity. GLP-1 is short for glucagon-like peptide-1. In plain terms, the medicine copies a gut hormone that tells your brain you are full and helps your body handle blood sugar after meals. Novo Nordisk developed it and sold it first as Ozempic and Rybelsus for type 2 diabetes, and as Wegovy for weight management.

Every new medicine is protected by a patent for a set number of years. While that patent holds, no other company can sell the drug. India’s main patent on semaglutide expired on 20 March 2026 (Business Standard, 2026). The very next day, Indian companies launched their own versions, each under its own brand name. That is how the same drug now sits on the shelf as Obeda, Semaglyn, Semasize and a dozen others.

India has one of the largest groups of people living with diabetes in the world, so demand was high and the launches came fast. [Type 2 Diabetes in Young Indians] has become common enough that many families were already waiting for a cheaper option. Within the first week, nine or more companies had a brand on the market (Pearce IP, 2026).

The full list of semaglutide brands in India

More than a dozen companies now sell semaglutide in India, most under several brand names each.

The table below lists the main makers and their brands so you can recognise what you are being offered. This is for identification, not ranking. Which brand suits you, if any, is a decision for you and your doctor.

Sources: company announcements, Pearce IP and The Hindu, 2026.

Many more names are on the way. Industry watchers estimate that over 50 semaglutide brands in India, from more than 40 companies, could be on sale through 2026 (The Hindu, 2026). The list above covers the makers with the clearest public information so far.

Injectable and tablet forms are not the same story

Almost every Indian generic semaglutide is an injection. The tablet form is still mainly the original Rybelsus.

Here is the part that trips people up. The patent that expired in March 2026 opened the door for injectable semaglutide. The tablet, Rybelsus, is harder to copy. It uses a special ingredient called SNAC that helps the medicine survive stomach acid and get absorbed, and that absorption technology carries its own separate patent.

This is why Novo Nordisk did not cut the price of Rybelsus in India even as it slashed the price of its injections. The tablet still faces little generic competition (Business Standard, 2026). One Indian company, Torrent, has announced both an injectable and an oral semaglutide. But as of the middle of 2026, if you want the tablet, the main option in India remains Rybelsus.

So when people search for semaglutide tablet brands in India, the honest picture is this: the tablet market is thin, and the real competition is happening in the weekly injection.

Semaglutide price in India, from about Rs 1,290 a month

Generic semaglutide injections in India start at roughly Rs 1,290 a month, far below the original brands.

Prices vary by company, by dose, and by whether you buy a vial or a pen. Vials tend to cost less than pens. The figures below are starting prices for the lowest doses, taken from company announcements around launch. They move a little by pharmacy and change over time, so check before you buy.

Sources: Pearce IP, CNBC, Astute Analytica and company announcements, 2026.

The cheapest way in is a vial, which lets a nurse or pharmacist draw each dose. A pen is easier to use at home but usually costs more. Higher doses cost more than starting doses in every brand, so your monthly bill rises as your dose goes up.

If you are taking one of these medicines to manage blood sugar, tracking your numbers matters as much as the brand you pick. Our [Normal Blood Sugar Levels Chart] shows what those readings mean.

How the generics compare with Ozempic, Wegovy and Rybelsus

Novo Nordisk’s original brands cost several times more than the generics, even after two price cuts in India.

Novo Nordisk launched Wegovy in India in June 2025 and Ozempic in December 2025. As the Indian generics arrived, the company cut its injection prices twice. By the end of March 2026, the lowest dose of both Ozempic and Wegovy was priced at Rs 1,415 a week, or about Rs 5,660 a month, down from around Rs 8,800 and Rs 10,850 (Business Standard, 2026).

Sources: Business Standard and CNBC, 2026. Prices are for starting doses and change with dose and pharmacy.

The gap is wide. A generic vial can cost less than a quarter of the original pen at the starting dose. For a medicine that people often stay on for years, that difference adds up over time. If you are already on Ozempic and thinking about a switch, our guide to [Ozempic Price in India] covers the brand in detail.

Are the cheaper Indian brands as good as the original?

Yes. An approved generic contains the same molecule and works the same way as the original.

A generic is not a lower quality copy. It is the same active medicine, made to a set standard, once the original patent ends. Indian semaglutide brands were approved by the drug regulator, the DCGI. Several companies also completed clinical trials in Indian patients before launch. Alkem, for one, was cleared after its Phase 3 trial results in India were reviewed (Pearce IP, 2026).

What changes between brands is the device in your hand and the price on the bill, not the medicine inside. A pen from a large, well-known maker may feel easier to use than a vial, and that is a fair reason to choose it. A cheaper vial from an approved company still holds the same semaglutide.

Two honest cautions belong here. Not all semaglutide brands in India carry the same weight of published trial data, so if the evidence behind a name matters to you, ask your doctor which brands they trust. And price alone should not settle it. The right choice balances cost, how you will give the injection, and your own health.

What each brand is approved for

Some brands are approved only for type 2 diabetes, some only for weight management, and some for both.

This matters because using a diabetes-only brand for weight loss, or the reverse, is off-label. Your doctor decides what fits your situation.

Sources: company announcements and Pearce IP, 2026.

Novo Nordisk uses different brands for different jobs, and so does Sun Pharma. Others, like Zydus and Alkem, cover both uses with one set of brands. If weight is your main worry, our note on [Prediabetes in Normal Weight Indians] explains why the picture is not always about the number on the scale.

Semaglutide is not insulin, and it is not Mounjaro

Semaglutide is a GLP-1 medicine, not insulin, and it is a different drug from Mounjaro.

This confuses a lot of people, so it helps to be clear. Insulin replaces a hormone your body cannot make enough of. Semaglutide does something else. It helps your own body respond better after meals and lowers your appetite. If you are comparing weekly injections and want to understand weekly insulin instead, see our guide to the [Awiqli Insulin Price in India].

Mounjaro is a separate medicine again. It contains tirzepatide, a newer molecule made by Eli Lilly. Here is how the two compare.

Sources: Pearce IP, 2026 and FDA, 2026.

Because Mounjaro has no Indian generic yet, it has not seen the same price crash. Our comparison of [Mounjaro vs Ozempic] lays out the differences in more detail.

Side effects are the same across every brand

Because the medicine is identical, the side effects of any approved semaglutide brand are the same.

The most common ones are stomach related: nausea, vomiting, diarrhoea and constipation, most often in the first weeks and after a dose increase (Mayo Clinic, 2025). These usually ease as your body settles. Starting on a low dose and going up slowly is what keeps them manageable.

Less common but more serious problems can include inflammation of the pancreas, gallbladder trouble, and low blood sugar if semaglutide is taken alongside insulin or certain diabetes tablets (FDA, 2026). None of this changes with the brand.

Who should not take semaglutide

Semaglutide is not safe for everyone, and switching to a cheaper brand does not change that.

Some people should not take it at all. The reasons come from the medicine itself, not from any one company.

Sources: FDA Ozempic prescribing information, 2026.

Other conditions do not rule it out, but your doctor needs to know first. Tell them if you have ever had pancreatitis, gallstones, kidney trouble, or a stomach problem that slows digestion. Eye damage from diabetes matters too, because blood sugar that falls quickly can make it worse for a while, so your doctor may want your eyes checked (FDA, 2026). If you already take insulin or a sulfonylurea tablet, your dose may need lowering to avoid low blood sugar.

Semaglutide also slows how fast the stomach empties, which can change how your other tablets are absorbed (FDA, 2026). Bring your full medicine list to the appointment, not just a mental note of it.

How to choose a brand with your doctor

With so many semaglutide brands in India to choose from, the decision can feel harder than it should. The best brand is the one that fits your health need, your budget, and how comfortable you feel giving the injection.

A few things are worth checking together:

• What it is approved for. Match the brand to your reason for taking it, diabetes or weight.
• Vial or pen. Vials cost less but need careful measuring. Pens are simpler to use but pricier.
• The maker’s track record. Larger companies often have more published data behind them.

Whatever you settle on, semaglutide is always started at a low dose and raised slowly over weeks to reduce side effects. That build-up is the same across brands, and it needs a doctor’s guidance. Watching your longer-term control through your [HbA1c Normal Range Chart] helps you and your doctor see whether the medicine is doing its job.

How to store semaglutide

Keep semaglutide in the fridge between 2°C and 8°C until you use it for the first time, and never freeze it.

Storage is one place where the brand and the device genuinely matter. A pen or vial that has been too warm may quietly stop working, and you cannot tell by looking.

The rules for the injection are broadly the same across brands. Before first use, keep it in the fridge, away from the cooling element at the back, and out of the freezer. After you start a multi-dose pen, it can sit either in the fridge or below 30° C, and it must be thrown away 56 days after first use even if medicine is left inside (FDA, 2026). Keep the cap on, and keep it out of direct sunlight.

Indian summers are the catch here. That 30 C room-temperature allowance comes from the label, and in much of India a room easily crosses 30 C from April to June. So for most families the fridge is the safer default, not the shelf. If the power goes for long stretches, ask your pharmacist about a cool pack for travel days.

Do not use the medicine if it has frozen or if the liquid looks cloudy or has bits floating in it. Tablets are different again. Rybelsus is stored at normal room temperature in its own bottle with the cap shut, kept away from damp (Novo Nordisk, 2026).

One brand-specific warning. Generic vials are the cheapest way to buy semaglutide in India, but a vial is opened and used more than once, so its in-use limit can differ from a pen’s. Read the leaflet that comes in your box rather than assuming the pen rule applies.

What to do if you miss a dose

If you miss your weekly semaglutide injection, take it as soon as you can within 5 days, then go back to your usual day.

If more than 5 days have gone by, skip that dose completely. Take the next one on your regular day and carry on as normal (FDA, 2026). Do not take two doses to catch up.

Never give two injections less than 2 days apart. If you want to move your weekly injection to a different day, that is allowed, as long as there are at least 2 days between one dose and the next (FDA, 2026).

The tablet works on a different rule because it is taken daily. If you miss a dose of Rybelsus, skip it and take the next one the following day at your usual time (Novo Nordisk, 2026). Do not take two tablets in one day.

Missing a single weekly dose is not a disaster. Semaglutide stays in the body for weeks, so one gap will not undo your progress. Missing several in a row is different, and your doctor may want to restart you at a lower dose to keep side effects manageable.

What patients often get wrong

The most common mistake is thinking a cheaper brand must be weaker. It is not.

When the price of a medicine falls by most of its value almost overnight, it feels too good to be true. But that fall came from competition after a patent ended, not from any drop in quality. The molecule is the same in the Rs 1,290 vial and the original pen.

The second mistake is treating semaglutide as a quick fix you can start on your own. It is a prescription medicine in India for good reason. It needs a slow dose build-up and regular monitoring, and it is not right for everyone. Buying it without a prescription, or from an unverified online seller, is a real risk. India’s drug regulator has warned companies against promoting these medicines for casual weight loss.

The third mistake is stopping too soon. Semaglutide works while you take it. If you stop, appetite and weight often return, and blood sugar can climb again. It is meant for the long run, not a few weeks.

Clinical Note:
During my clinical training in Jaipur, including at SMS Medical College Hospital and RUHS Medical College Hospital, I met many people who delayed treatment because they believed all diabetes medicines or injections worked the same way. Some assumed a lower priced medicine had to be less effective, while others wanted to change medicines without speaking to a doctor. Those conversations taught me that clear, practical information matters just as much as the prescription itself. That is why this guide explains semaglutide in the same clear and practical way patients expect from a healthcare professional.

When to see a doctor

Do not start, stop, or switch a semaglutide brand on your own. Every price and name in this guide is the start of a conversation, not a prescription.

Book an appointment before you begin if you have type 2 diabetes, a weight concern, or you are already on Ozempic or Wegovy and want to move to a generic. Your doctor will match the brand to your need and set your starting dose.

See your doctor soon if you have ongoing nausea or vomiting that stops you eating or drinking, stomach pain that spreads to your back, signs of low blood sugar such as shaking, sweating and confusion, or any yellowing of the skin or eyes.

Emergency symptoms

Get emergency help straight away if you have severe stomach pain that will not settle, especially with vomiting, which can be a sign of inflammation of the pancreas.

Call for emergency help too if low blood sugar brings confusion, a seizure, or loss of consciousness, or if you have a rash over your body with swelling of the face, lips or throat and trouble breathing, which can signal a serious allergic reaction (FDA, 2026).

The bottom line

Semaglutide in India is now one medicine wearing many names. After the March 2026 patent expiry, brands like Obeda, Semaglyn, Semasize, Sematrinity and Semabest joined Novo Nordisk’s Ozempic, Wegovy and Rybelsus, and prices fell hard. A generic injection can start near Rs 1,290 a month against about Rs 5,660 for the original.

The medicine inside every approved brand is the same. What differs is the maker, the device, and the price. The tablet form is still mostly Rybelsus for now. Take these names and numbers to your doctor, and let the choice be about your health first and your budget second.

Frequently asked questions

Which is the cheapest semaglutide brand in India?

Vial-based generics are the cheapest. Brands like Eris Sundae and Natco Semanat start at about Rs 1,290 a month for the lowest dose, and some vial options work out even lower per injection (Health and Me, 2026). Vials cost less than pens but need careful measuring by a nurse or pharmacist. Your final price depends on your prescribed dose, since higher doses cost more.

Are Indian generic semaglutide brands as effective as Ozempic?

Yes. An approved generic holds the same semaglutide molecule and works the same way as Ozempic. Indian brands were cleared by the DCGI, and several completed trials in Indian patients before launch (Pearce IP, 2026). The difference is the price and the injection device, not the medicine. Choose with your doctor based on your health need and how you will give each dose.

Is there a semaglutide tablet brand in India?

The main tablet is still Novo Nordisk’s Rybelsus. The March 2026 patent expiry mostly affected injections. The tablet uses a separate absorption technology called SNAC that carries its own patent, so generic tablets are limited (Business Standard, 2026). One company, Torrent, has announced an oral version, but for now the tablet market in India is thin compared with the weekly injection.

Can I buy semaglutide without a prescription in India?

No. Semaglutide is a prescription-only medicine in India. It needs a slow dose build-up and monitoring, and it is not safe for everyone. Buying it without a prescription or from an unverified seller is risky, and the drug regulator has warned against promoting it for casual weight loss. Always start it under a doctor’s care and stay under review.

What is the difference between Ozempic and Wegovy in India?

Both contain semaglutide, but they are approved for different reasons. Ozempic is for type 2 diabetes and goes up to a 1 mg weekly dose. Wegovy is for weight management and goes up to a higher 2.4 mg dose. After price cuts in 2026, both start at about Rs 5,660 a month for the lowest dose in India (Business Standard, 2026).

Which semaglutide brand is best for weight loss in India?

For weight, the brand must be approved for that use. Novo Nordisk’s Wegovy is the original approved for weight management, and generic brands such as Zydus Semaglyn, Alkem Semasize, MSN Semabest and Sun Pharma Noveltreat carry weight-management approval too (Pearce IP, 2026). Your doctor picks the right one for your health and sets the dose. There is no single best brand for everyone.

Is semaglutide the same as Mounjaro?

No. Semaglutide and Mounjaro are different medicines. Mounjaro contains tirzepatide, which acts on two hormone pathways instead of one, and it is made by Eli Lilly. It is still under patent, so there is no Indian generic yet. It has often shown greater weight loss in trials but has its own cost and side effects. See [Mounjaro Injection Price in India] for details.

Why is Rybelsus more expensive than the injectable generics?

Rybelsus is a tablet, and the tablet is harder to copy. It relies on an absorption ingredient called SNAC with its own patent, so it faces little generic competition in India. Novo Nordisk kept its price steady even while cutting its injection prices (Business Standard, 2026). At about Rs 2,300 to 3,300 a month, it costs more than many generic injections.

Does CGHS or insurance cover semaglutide in India?

Coverage depends on your scheme and on why the medicine is prescribed. Government schemes like CGHS and ESI cover medicines on their approved lists, and a newly launched drug can take time to be added. Weight-management use is often not covered, while diabetes use may be. Ask your scheme office directly rather than assuming, since the rules change.

Can I switch from Ozempic to a generic semaglutide brand?

Often yes, but only with your doctor’s guidance. Because the molecule is the same, switching from Ozempic to an approved generic at the matching dose is usually straightforward. Your doctor will confirm the right brand and dose and check that the device suits you. Do not switch on your own or change your dose while switching.

References

1. Pearce IP. Generic semaglutide launches in India, including by Dr Reddy’s, Zydus, Alkem, Sun Pharma and Glenmark. 2026. pearceip.law
2. Business Standard. As generics wave builds up, Novo Nordisk slashes Ozempic, Wegovy prices in India. 2026. business-standard.com
3. CNBC. India is launching cheap weight-loss drugs, but Novo Nordisk is betting its brands will stay on top. 2026. cnbc.com
4. The Hindu. Sun Pharma, Dr Reddy’s, Zydus, Glenmark roll out generic semaglutide. 2026. thehindu.com
5. Astute Analytica. MSN Labs launches affordable semaglutide generic in India. 2026. astuteanalytica.com
6. Health and Me. NATCO Pharma first to launch generic semaglutide in India. 2026. healthandme.com
7. Dr Reddy’s Laboratories. Semaglutide (Obeda) launch press release. 2026. drreddys.com
8. Sun Pharmaceutical Industries. Semaglutide (Noveltreat and Sematrinity) launch press release. 2026. sunpharma.com
9. MarketScreener (Reuters). Ozempic launches in India with Novo Nordisk pricing. 2025. marketscreener.com
10. Mayo Clinic. Semaglutide (subcutaneous route): side effects. 2025. mayoclinic.org
11. US Food and Drug Administration. Ozempic (semaglutide) injection: full prescribing information, NDA 209637. 2026. accessdata.fda.gov
12. National Health Service (NHS). Semaglutide and GLP-1 medicines. 2025. nhs.uk
13. Novo Nordisk. Rybelsus (semaglutide) tablets: how to take and store. 2026. rybelsus.com

Medically reviewed by

This guide was checked for medical accuracy by our review board before publishing.

Dr Praveen Verma, MBBS, MD (Pathology), Pathologist and Clinical Laboratory Specialist.

Dr Himanshu Morya, MBBS, Medical Educator.

Kalpna Singh Shekhawat, BSN, RN.

About the author

Iraphan Khan, BSN, RN, D.Pharm, Public Health Researcher is the founder of RealMedVision and creates evidence-based health content from trusted medical sources.

Medical disclaimer

This article is for education only. It is not medical advice and cannot replace a consultation with your own doctor. Do not start, stop, or change any semaglutide medicine on your own. If you have severe stomach pain, or if low blood sugar brings confusion, seizures, or fainting, get emergency help at once.